Accueil・Liste d'Actions・Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

Fermé

28.6 0.07

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

27.87

Max

28.6

Chiffres clés
By Trading Economics
Revenu	-20M -40M
Ventes	679K 72M
BPA	-0.1
Marge bénéficiaire	-55.82
Employés	624
EBITDA	2.3M -12M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	-9.81% downside

Dividendes
By Acuity
Prochains Résultats	4 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	347M 4B
Ouverture précédente	28.53
Clôture précédente	28.6

Adaptive Biotechnologies Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 sept. 2026, 23:56 UTC

Targa Resources Corp is trading modestly higher in after-market hours, recovering from an early decline and reaching a high near the session's end.

17 sept. 2026, 23:56 UTC

Correlated Moves

Synaptics Inc declined during after-market hours, moving lower alongside the Nasdaq 100 Index amid positive economic data, including a drop in jobless claims.

17 sept. 2026, 23:56 UTC

TransUnion is trading modestly higher in after-market hours, despite earlier gains settling and the price remaining below its 20-day moving average.

17 sept. 2026, 23:56 UTC

Event

News

Rexford Industrial Realty completed a $1.2 billion sale of a 22-property portfolio to EQT Real Estate, with shares slightly declining in after-market trading.

17 sept. 2026, 23:56 UTC

Correlated Moves

Saia Inc's shares traded roughly flat during after-market hours, remaining below the 20-day moving average and near the lower end of its one-month range.

17 sept. 2026, 23:56 UTC

Fidelity National Information Services Inc is trading modestly higher in after-market hours following four consecutive sessions of losses, amid positive economic indicators.

17 sept. 2026, 23:52 UTC

Pinterest Inc is trading higher in after-market hours, continuing a trend of higher daily closes since Thursday's close, despite recent divergence from upward momentum.

17 sept. 2026, 23:51 UTC

Organon & Co. is experiencing a modest decline in after-market trading, remaining below its 20-day moving average and near the lower end of its one-month trading range.

17 sept. 2026, 23:51 UTC

Hawkins Inc is advancing in after-market trading, reaching its highest cumulative return of the day amid a one-month trading range.

17 sept. 2026, 23:51 UTC

Turning Point Brands Inc has advanced in after-market trading, recovering sharply from a low immediately following Thursday's close, contributing to an overall higher position.

17 sept. 2026, 23:51 UTC

TransDigm Group Inc is seeing modest gains in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

17 sept. 2026, 23:51 UTC

American Electric Power Company Inc is trading modestly lower in after-market hours, continuing a decline from Thursday's close and remaining below its 20-day moving average.

17 sept. 2026, 23:51 UTC

Alliant Energy Corp is trading modestly higher in after-market hours, showing stability with slight upward movement and fluctuations within a narrow range.

17 sept. 2026, 23:51 UTC

Correlated Moves

BHP Group Ltd is advancing in after-market trading, reflecting a notable upward movement since Thursday's close, despite remaining below its 20-day moving average.

17 sept. 2026, 23:51 UTC

CRISPR Therapeutics AG declined modestly during after-market hours on Thursday, breaking a recent trend of higher daily closes.

17 sept. 2026, 23:51 UTC

Chicago Fed National Activity Index Release on September 21, 2026: Market Awaits Insights Amid Cautious Optimism and Inflation Concerns.

17 sept. 2026, 23:51 UTC

Mortgage Rates Hit 6.97%, Highest Since May 2025, as Market Sentiment Wanes Ahead of Upcoming MBA Release

17 sept. 2026, 23:51 UTC

Japan's Core Inflation Rate for August at 1.7% Falls Short of Expectations, Raising Concerns Over Economic Stability and Monetary Policy Effectiveness

17 sept. 2026, 23:51 UTC

Japan's August Inflation Rate at 1.9% Falls Short of Expectations, Raising Concerns for Monetary Policy Adjustments Amidst Weak Demand

17 sept. 2026, 23:51 UTC

Correlated Moves

Las Vegas Sands Corp is trading modestly higher in after-market hours, following a pullback earlier in the session, aligning with Wynn Resorts Ltd's gains.

17 sept. 2026, 23:51 UTC

Regeneron Pharmaceuticals Inc is trading modestly lower in after-market hours, remaining significantly below its 20-day moving average after a volatile session.

17 sept. 2026, 23:51 UTC

FedEx Corp is trading modestly lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month trading range.

17 sept. 2026, 23:51 UTC

ICU Medical Inc declined in after-market trading, reaching its lowest point shortly after the market closed and remaining below its 20-day moving average.

17 sept. 2026, 23:51 UTC

In after-market trading, Dave and Buster's Entertainment, Inc. is advancing, reflecting a notable increase since Thursday's close, despite being below its 20-day moving average.

17 sept. 2026, 23:51 UTC

SLB NV is trading modestly higher in after-market hours, following fluctuations that led to a cumulative return of 0.89% shortly after the market closed.

17 sept. 2026, 23:51 UTC

Correlated Moves

Cardinal Health Inc is trading modestly higher in after-market hours, following a slight uptick in Cencora Inc, which is recovering from recent declines.

17 sept. 2026, 23:51 UTC

Bath & Body Works Inc. is declining in after-market trading, currently near its lowest point of the day and below its 20-day moving average.

17 sept. 2026, 23:46 UTC

Ecolab Inc is trading modestly higher in after-market hours, though it remains below its 20-day moving average and near the lower end of its one-month range.

17 sept. 2026, 23:46 UTC

Daqo New Energy Corp is trading higher in after-market hours, closing at its highest point despite challenges, as U.S. jobless claims fell to 196k.

17 sept. 2026, 23:46 UTC

N-Able Inc gained in after-market trading, advancing since Thursday's close and stabilizing above its 20-day moving average near the upper end of its one-month range.

Comparaison

Variation de prix

Adaptive Biotechnologies Corp prévision

Objectif de Prix

By TipRanks

-9.81% baisse

Prévisions sur 12 Mois

Moyen 25.75 USD -9.81%

Haut 28 USD

Bas 22 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

Achat

Maintien

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.